Clinical Trial Detail

NCT ID NCT02834052
Title Pembrolizumab + Poly-ICLC in MRP Colon Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Samir N. Khleif
Indications

colon cancer

Therapies

Pembrolizumab + poly ICLC

Age Groups: adult senior

No variant requirements are available.